Shearman & Sterling represented Merrill Lynch, Pierce, Fenner & Smith Incorporated and RBS Securities Inc. as joint book-running managers and representatives of the several underwriters in connection with a public offering of $800 million aggregate principal amount of senior notes of Life Technologies Corporation. Life Technologies Corporation is a global biotechnology tools company that provides its customers with systems and reagents that enable a broad spectrum of biological research of genes, proteins and cells within academic and life science research and commercial applications.

The Shearman & Sterling team included partners Michael Schiavone (New York-Capital Markets) and Lona Nallengara (New York-Capital Markets); counsel Jeffrey Salinger (New York-Property/Environmental); associates Marwa Elborai (New York-Capital Markets), Anthony Mascarenhas (New York-Capital Markets), Jordan Altman (New York-Intellectual Property Transactions), Timothy Franklin (New York-Intellectual Property Transactions), Christopher Greer (New York-Property/Environmental), and Shiu-Kay Hung (New York-Tax); and legal assistant Kristi-Anne Nadvornik (New York-Capital Markets).